Drawing for BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO

USPTO serial 79412652

BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO

Reviewed by CopyMark Law Group

Reg. 8226557Status 700Registered
Filing date
Status date
Registration date
Apr 28, 2026
Examiner
SMITH, BRENDAN K
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori S. Kozak

Lori S. Kozak Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United States

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes, namely, for cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; diagnostic preparations for medical purposes; medicines for veterinary purposes for the treatment of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides * , other than for agricultural purposes * ; sterilizing preparations * , other than for agricultural purposes * ; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, alzheimer's disease, and diabetes and its complications; pharmaceutical preparations for cancer supportive care; anesthetic for surgical purposes, sedative and analgesic drugs; vaccines; reagent paper for medical purposes; vitamin preparations; candy, medicated; cough pastilles for pharmaceutical purposes; mint for pharmaceutical purposes; chewing gum for medical purposes; lecithin for medical purposes; greases for medical purposes; cod liver oil; [ medicinal preparations for the mouth to be applied in the form of capsules; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental materials, namely, dental sealants, adhesives, amalgams, ceramics, abrasives, cements, alloys, wax, polish; baby diapers; infant diapers; adult diapers; baby diaper covers; infant diaper covers; adult diaper covers; ] fly catching paper; mothproofing paper; lacteal flour for babies; glucose dietary supplements; lecithin dietary supplements; nutritional supplements; dietary supplements mainly consisting of seafood extracts in the form of powders, pills, capsules, granules, jellies or liquids; dietary supplements for humans; dietary fibre to aid digestion; lyophilized food adapted for medical purposes; lyophilized meat adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies being baby foods; food for babies; nutritional supplements for animals; dietary supplements for animals; semen for artificial inseminationACTIVE—
044Beauty salon services; barber shop services; providing bath houses; massage and therapeutic shiatsu massage; chiropractic services; moxibustion; medical treatment of dislocated joints, sprain, bone fractures; bodywork therapy; acupuncture; provision of medical information and information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via the Internet; provision of medical information relating to benefits, side effects, interactions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medical, medicinal and pharmaceutical consultancy; advisory services relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical products; provision of information on diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medical services through computer databases; medical testing for the collection of medical information, analysis and provision of medical information for diagnostic or treatment purposes; medical testing; medical consultancy and diagnosis of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications via the Internet; online medical counseling services; remote monitoring of medical data for medical diagnosis and treatment; analysis and provision of clinical data of patients for diagnostic or treatment purpose; provision of medical information; physical examination services; providing information about diagnostic, prophylactic and therapeutic properties of pharmaceuticals, medical services and health; consultancy services relating to medical services, diagnostic, prophylactic and therapeutic properties of pharmaceuticals, health and dispensing of medications; consultancy, advisory and provision of information relating to weight reduction diet planning, food nutritional intake and health care; consultancy, advisory and provision of information relating to health care; managed health care services; provision of records of personal health information data such as weight, body fat, body temperature, number of steps, sleeping hours and blood pressure; nutritional consultancy and advisory for preventing and decreasing obesity; provision of information about nutritional consultancy and advisory for preventing and decreasing obesity; dietary and nutritional guidance; animal breeding; veterinary services; beautification for animals, namely, animal grooming; nursing care; rental of medical apparatus and instrumentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Oct 27, 2026COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Oct 27, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 16, 2026A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Oct 5, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 10, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jul 28, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 4, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 28, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 28, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 11, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Feb 4, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 4, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 4, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 6, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 6, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 1, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 15, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 15, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 15, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 11, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2025RFNTREFUSAL PROCESSED BY IB—
May 21, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 21, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 26, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025DOCKASSIGNED TO EXAMINER—
Dec 20, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 20, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance